Company: FTSP
Filing Date: 2025-02-14
Form Type: 8-K
Source: 0001199835-25-000044
Chunk: 18

Company: FinTrade Sherpa, Inc.
Filing Date: 2025-02-14
Form: 8-K
Item: Item 2.01
Chunk 18
---
 reporting requirements of Section 13 or 15(d) of Exchange Act;  
 ───────────────────────────────────────────────────────────────────────────────────────────────

  (iii)      we                                                                                           
             filed all Exchange Act reports and material required to be filed, as applicable, during the  
             preceding 12 months, other than Current Reports on Form 8-K; and                             
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────

  (iv)      at                                                                                           

There
can be no assurance that we will ever meet these conditions or that holders of our shares of Common Stock will be entitled to rely on
Rule 144 for the resale of their shares. This could have a materially adverse effect on the trading market for our shares, if a trading
market develops, of which there is no assurance.

Future
sales of our Common Stock could adversely affect our stock price and our ability to raise capital in the future, resulting in our inability
to raise required funding for our operations.

Any
sales of substantial amounts of our Common Stock in the public market, or the perception that those sales might occur, could harm the
market price of our Common Stock. Further, certain stockholders have “piggy-back” registration rights afforded
to them if we file a registration statement with the SEC; these shares or any registered securities we may register can also have an
adverse effect on any market for our Common Stock. The issuance of additional shares would dilute the value of our outstanding
shares of Common Stock.

Our
principal stockholders and management own a significant percentage of our Common Stock and will be able to control matters subject to
stockholder approval.

As
of immediately after the Closing, our executive officers, directors and holders of 5% or more of our capital stock beneficially owned
approximately 32.12% of our outstanding Common Stock. The interests of these stockholders may not be the same as or may even conflict
with the interests of other stockholders. For example, these stockholders could delay or prevent a change of control of the Company, even
if such a change of control would benefit other stockholders, which could deprive our other stockholders of an opportunity to receive
a premium for their common stock as part of a sale of our company or our assets and might affect the prevailing market price of our Common
Stock. The significant concentration of stock ownership may adversely affect the trading price of our Common Stock due to investors’
perception that conflicts of interest may exist